Equities

Lumiera Health Inc

NHP.H:NEX

Lumiera Health Inc

Actions
  • Price (CAD)0.005
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Apr 17 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Lumiera Health Inc. is a Canadian company that specializes in the development and commercialization of natural health products. Its brands consist of Holizen Laboratories, Awaye pain relief cream, and Bazzzics. Through its Holizen Laboratories division, the Company sells both oral and topical formulations to help manage a range of therapeutic needs, including a new generation of natural sleep-aids. The Company is also engaged in commercializing a topical product line acting on the endocannabinoid system, without the use of cannabis, which provides a solution for chronic pain and inflammation. Awaye is a topical product that works with the body's own endocannibinoid pain defense system and provides relief from both acute and chronic pain. Part of the Holizen portfolio, Bazzzics is a line of three formulas composed of sedative plant extracts that can be combined to address the customer's specific sleeping needs: pre-sleep serenity, fall asleep, and stay asleep.

  • Revenue in CAD (TTM)587.94k
  • Net income in CAD-2.34m
  • Incorporated2013
  • Employees--
  • Location
    Lumiera Health Inc4500 Blvd. KimberSAINT-HUBERT J3Y 8K5CanadaCAN
  • Phone+1 (450) 926-2442
  • Fax+1 (450) 926-2452
  • Websitehttps://www.lumiera.ca/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lumiera Health Inc587.94k-2.34m838.46k--------1.43-0.0138-0.01380.0035-0.01350.50962.1311.78---202.92------13.17---398.18--0.0395-2.10----46.91---188.58------
Hill Inc2.22m-1.97m1.02m----1.44--0.4587-0.6076-0.60760.68220.21590.5046129.234.56---44.92-77.46-48.92-101.0368.1450.14-89.01-153.932.97-4.230.7881---10.2333.8618.26--16.21--
Vitality Products Inc789.03k-193.76k1.04m--------1.31-0.0047-0.00470.019-0.03340.86491.146.42---21.24-28.04----72.2673.72-24.56-42.490.1719-------4.768.3149.92---0.619--
Data as of Apr 17 2023. Currency figures normalised to Lumiera Health Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.